Bioequivalence study of testosterone undecanoate soft capsules in healthy postmenopausal women under fed conditions: a single-center, four-period, repeated crossover trial
TU demonstrated bioequivalence to Andriol Testocaps<sup>®</sup> under fed conditions in Chinese healthy participants, with comparable safety and tolerability profiles. These results advocate the clinical application of generic TU as a potential alternative to originator drug Andriol Testocaps<sup>®</sup> in the treatment.
Authors
- Nanxing Li
- Shilong Zhu (ORCID: https://orcid.org/0009-0009-5147-6192)
- Jinlian Wu
- Xiuhui Qian
- Xi Zhang (ORCID: https://orcid.org/0000-0002-4638-3997)
- Zhongyuan Zhao (ORCID: https://orcid.org/0009-0006-8613-5257)
- Yuxiang Hu (ORCID: https://orcid.org/0009-0005-8536-3840)
- Fengjia Zhu (ORCID: https://orcid.org/0000-0003-2824-4798)
- Tiandong Zhang
- Xu Zuo
- Jing Chen
- Yueran Lv
- Jinjin Shi
Institutions
- Xihua University (CN)
- China Pharmaceutical University (CN)
- Donghua University (CN)
- Xinxiang Central Hospital (CN)
- Zhejiang Medicine (China) (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-03-03
- DOI
- https://doi.org/10.3389/fphar.2026.1763835
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00